Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DECIDE: Dapagliflozin vs Standard of Care in Type 2 Diabetes
NCT02616666Phase 4Completed
- Sponsor
- University of Liverpool
- Start
- Aug 2016
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of dapagliflozin in type 2 diabetes mellitus (T2DM), sponsored by University of Liverpool. Started Aug 2016; status: completed.
02
Drugs
dapagliflozin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02616666.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02616666.